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Clinical trials are sometimes classified as following
either an explanatory or pragmatic design. Explanatory
trials seek to investigate the efficacy of new treatments
by imposing strict limitations on the design of the trial,
including, for example, recruiting only those patients
who are most likely to respond, considering only the
most adherent patients in analyses or standardising trial
treatment. In contrast, the objective of pragmatic trials
is to assess whether treatments work in conditions more
appropriate to routine practice and are therefore often
much less restrictive in their design. This dichotomy is,
however, over simplistic; there is a continuum which
exists due to there being many areas of trial design that
can vary between the extremities of the explanatory and
pragmatic approaches.
The PRECIS (Pragmatic-Explanatory Continuum Indi-
cator Summary) wheel is a tool that proposes a way of
enabling researchers to assess the extent to which the
trials they are designing could be considered explanatory
or pragmatic. It is based on ten aspects of trial design,
including inclusion criteria, flexibility of delivery of the
intervention and intensity of follow-up. We consider
how the PRECIS tool can be applied in the design stage
of trials of tuberculosis treatment, to help teams design
trials in line with their purpose. In view of the well
recognised delay in getting results from well conducted
clinical trials into practice, we would suggest that if
more pragmatic trials are conducted, physicians would
better understand the implications of the results for
their own practice and be more ready to adopt new
treatments [1].
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